Your Cart is Empty
BUY 1 GET 1 FREE · AUTO APPLIES AT CHECKOUT
Medical Disclaimer | This article is for informational and educational purposes only and does not constitute medical advice. Alcohol and CBD each carry individual health considerations; their combination has not been extensively studied in humans. If you have concerns about alcohol use, please speak with a healthcare provider. The content on this page has not been evaluated by the FDA. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Individual results may vary.
Millions of people use CBD daily and also drink alcohol socially. The question of what happens when these two combine is more nuanced than a simple 'safe' or 'unsafe' answer — it depends on amounts, patterns of use, individual health context, and what you mean by 'what happens.'
The short version: combining CBD with one or two drinks on a casual social occasion, for most healthy adults, is not a significant safety concern — though the additive sedation potential means impaired judgment is possible at higher amounts of both. The longer concern is for people who drink regularly and use CBD daily at higher doses — the combined hepatic burden and CNS effects become more relevant to monitor over time.
The most scientifically interesting angle on this topic is actually CBD's potential for reducing alcohol cravings and intake — a harm reduction application with promising preclinical evidence. And then there's 'hangxiety' — the anxiety many people experience after drinking — which CBD's cortisol-modulating and anxiolytic properties are particularly well-suited to address. For the liver-specific picture, seeCBD and the Liver: What Long-Term Users Need to Know.
Understanding the interaction starts with understanding where the two compounds' mechanisms overlap:
Alcohol (ethanol) produces its effects primarily through GABA-A receptor potentiation and NMDA glutamate receptor inhibition — slowing CNS activity, producing anxiolysis, sedation, and at higher doses, impaired motor control, judgment, and coordination. Alcohol also activates the brain's reward circuits via dopamine release in the nucleus accumbens, driving the reinforcing properties that underlie alcohol use disorder.
CBD has documented GABAergic activity — positive allosteric modulation of GABA-A receptors at higher doses. This overlapping GABA pathway is the basis for the additive sedation concern when CBD and alcohol are combined. CBD also shares alcohol's anxiolytic dimension (via 5-HT1A rather than GABA primarily) and its cortisol-blunting properties — which is why the combination at low doses may feel calmer and more relaxed than either alone, but at higher amounts of both may produce more sedation than expected.
The most cited direct study on CBD and alcohol comes froma 1979 study in Psychopharmacology — one of the earliest pharmacological studies on CBD in humans. Ten volunteers received CBD alone, alcohol alone, CBD plus alcohol, or placebo in a crossover design. Findings: the CBD plus alcohol combination produced significantly lower blood alcohol concentrations than alcohol alone, and participants in the CBD + alcohol group showed greater impairment on psychomotor tasks than alcohol alone despite lower BAC. This suggests CBD may affect alcohol's pharmacokinetics (slowing absorption or increasing distribution) while simultaneously adding its own CNS effects — producing greater functional impairment at lower blood alcohol levels.
Important limitation:This was a very small study from 1979 using different CBD formulations than modern products, at doses not easily comparable to current supplement use. It has not been replicated in a modern clinical trial. The finding is directionally informative but should not be treated as definitive guidance for modern CBD products.
More recent and more compelling research examines CBD's potential to reduce alcohol intake and craving. A2019 study in Neuropsychopharmacology found that a transdermal CBD gel significantly reduced alcohol-seeking behavior, self-administration, and relapse in a rat model of alcohol use disorder — with effects that persisted well beyond the CBD treatment period. A2019 pilot study in Psychopharmacologyexamined CBD in a small group of human heavy drinkers and found that CBD significantly reduced cue-induced alcohol craving and anxiety. The mechanism is thought to involve CBD's ECS modulation of reward circuits — reducing the salience of alcohol cues and dampening the stress-reactivity that drives relapse.
|
Interaction Area |
What Happens |
Direction |
Evidence Level |
Practical Implication |
|
Blood alcohol levels |
CBD may modestly reduce peak blood alcohol concentration when taken together |
CBD reduces BAC slightly |
One 1979 human RCT; limited replication; effect size modest |
CBD is not a meaningful way to reduce intoxication — don't rely on it for impairment reduction |
|
Sedation / motor impairment |
Additive CNS depression — both alcohol and CBD produce sedation through GABA pathways; combined effect may exceed either alone |
Additive — greater impairment possible |
Moderate — GABA additive mechanism well-understood; direct combination studies limited |
Do not drive or operate machinery after combining CBD and alcohol; sedation may be greater than expected |
|
Nausea / vomiting (acute) |
CBD's anti-emetic properties (CB1 brainstem, 5-HT3 antagonism) may reduce alcohol-induced nausea; anecdotally reported |
CBD may reduce nausea |
Mechanism strong; direct CBD-alcohol nausea study absent |
Plausible benefit; not a substitute for moderation |
|
Liver stress |
Both alcohol and CBD are processed by the liver; CYP2E1 (alcohol) and CYP3A4/2C19 (CBD) pathways are different; modest additive hepatic load at high doses of both |
Additive hepatic stress at high doses |
Mechanism-based; see liver guide for CBD-specific liver data |
Regular heavy alcohol + high-dose CBD daily = meaningful hepatic burden; minimize combined exposure |
|
Alcohol cravings / addiction |
Preclinical evidence suggests CBD reduces alcohol self-administration and cue-induced reinstatement; one small human pilot study positive |
CBD may reduce cravings |
Promising preclinical; very limited human data; not established as treatment |
Not a substitution therapy; encouraging research for harm reduction context |
|
Anxiety after drinking |
CBD's anxiolytic effect may blunt alcohol-induced next-day anxiety ('hangxiety'); mechanism via HPA cortisol modulation |
CBD may reduce hangxiety |
Mechanism plausible; no direct study; anecdotal reports strong |
One of the most commonly reported benefits by CBD + occasional drinker users |
|
Sleep quality |
Alcohol disrupts sleep architecture (suppresses REM, causes fragmented sleep); CBD improves sleep quality; combined effect variable depending on amounts |
Variable — small alcohol may synergize; larger amounts override CBD's sleep benefit |
Well-established alcohol sleep disruption; CBD sleep evidence strong; combination not studied |
CBD's sleep benefit may be partially offset by alcohol's REM suppression at higher drinking quantities |
Both CBD and alcohol are processed by the liver — though through different enzymatic pathways. Alcohol is primarily metabolized by alcohol dehydrogenase (ADH) and CYP2E1; CBD by CYP3A4 and CYP2C19. These are different enzymes, so they don't directly compete for the same metabolic machinery in the way that, say, two CYP3A4-processed drugs might. However, both substances impose hepatic processing burden, and regular combined use at higher levels of each compounds the cumulative stress on liver function.
The detailed liver picture is covered inCBD and the Liver: What Long-Term Users Need to Know. The short version here: occasional moderate drinking alongside daily low-dose CBD is not a significant liver concern for healthy adults. Regular heavy drinking (4+ drinks/night) combined with high-dose CBD (150mg+ daily) represents meaningful combined hepatic burden that warrants liver function monitoring and physician awareness.
'Hangxiety' — the anxiety, dread, and low mood experienced the morning after drinking — is one of the most commonly reported reasons CBD users reach for their oil the day after social drinking. The mechanism has a coherent explanation:
Practical protocol:Many CBD users take their usual morning dose ofNano CBD Oil the morning after drinking as their first action alongside hydration. The cortisol modulation and 5-HT1A anxiolytic effect kick in within 30–60 minutes — addressing the hangxiety mechanism directly rather than waiting it out.
|
Use Pattern |
Liver Risk |
CNS Risk |
Sleep Impact |
Overall Guidance |
|
Daily CBD (25mg) + Occasional 1–2 drinks |
Low — modest additive hepatic load; well within normal liver capacity for healthy adults |
Low — modest additive sedation unlikely to be problematic at these amounts |
Minimal — small alcohol amount unlikely to significantly override CBD sleep benefit |
Acceptable for healthy adults; monitor for unusual sedation; maintain good liver health |
|
Daily CBD (25mg) + Regular moderate drinking (3–4 drinks/night) |
Moderate — regular alcohol is independently hepatotoxic; combined with daily CBD adds processing burden |
Moderate — regular alcohol disrupts HPA and sleep architecture; CBD partially counteracts but doesn't eliminate |
Moderate negative — regular alcohol significantly disrupts sleep; CBD helps but won't fully compensate |
Physician disclosure recommended; liver function monitoring if sustained over months; reduce combined exposure |
|
High-dose CBD (150mg+) + Regular drinking |
Moderate-High — high-dose CBD plus regular alcohol produces meaningful combined hepatic load; liver enzyme monitoring warranted |
Moderate-High — sedation risk more significant at high CBD doses |
Negative — high-dose CBD's sedative effects may combine with alcohol disruption |
Physician involvement warranted; LFT monitoring; reduce one or both |
|
CBD for alcohol cravings reduction |
Depends on CBD dose — therapeutic alcohol reduction goal; follow harm reduction guidance |
Positive — reducing alcohol consumption improves CNS health |
Positive — less alcohol = better sleep |
Promising application; discuss with addiction specialist; CBD not a standalone alcohol use disorder treatment |
|
Acute CBD before drinking (party / event use) |
Low — single-occasion combination at typical doses; liver not significantly stressed |
Moderate — additive sedation; impaired judgment possible; do not drive |
N/A for acute use |
Use caution; avoid driving; expect potentially greater sedation than either alone |
The most scientifically interesting CBD-alcohol application — and the one with the most promising research trajectory — is CBD's potential to reduce alcohol craving and intake. If the preclinical evidence translates to humans at scale, CBD may offer a non-addictive, non-sedating option for supporting reduced alcohol use in people who drink heavily.
The mechanisms being explored:ECS modulation of reward circuitry (the same dopamine and nucleus accumbens pathways that alcohol hijacks), CBD's reduction of the stress-reactivity and anxiety that drive relapse, and CBD's potential normalization of the HPA dysregulation that characterizes chronic heavy alcohol use.
What this isn't:CBD is not an established treatment for alcohol use disorder. It has not been approved for this use. A small pilot human study and encouraging animal research represent early-stage evidence — promising but not clinical practice-changing. People with alcohol use disorder should work with addiction medicine specialists. CBD may be a useful complementary support but not a standalone intervention for AUD.
For most healthy adults, combining CBD at typical supplement doses with moderate social drinking (1–3 drinks) is not a significant safety concern. The main practical caution is additive sedation — the combination may produce greater impairment than either alone, which matters for driving and other activities requiring alertness. For people with liver disease, on other medications, or drinking heavily regularly, the risk picture is more complex and physician awareness is appropriate.
CBD addresses the anxiety component of a hangover (hangxiety) through cortisol modulation and 5-HT1A anxiolysis better than the headache component. CBD's anti-inflammatory properties may have some relevance to the inflammatory component of hangover symptoms. CBD doesn't accelerate alcohol metabolism or address dehydration — so hydration and time remain the most fundamental hangover interventions, with CBD's most reliable contribution being to the anxiety and cortisol rebound dimension.
A 1979 study found modestly lower blood alcohol concentrations when CBD and alcohol were combined vs. alcohol alone. However, this study used formulations and dosing not comparable to modern CBD products, was very small, and has not been replicated in 45+ years. Relying on CBD to meaningfully reduce blood alcohol levels — for driving decisions or other impairment-sensitive purposes — would be dangerous and unsupported by current evidence.
Preclinical evidence (animal studies) and one small human pilot study suggest CBD may reduce alcohol craving and cue-induced relapse. This is a promising research direction but not an established clinical application. If you're trying to reduce alcohol consumption, discussing CBD as one component of a harm reduction approach with your healthcare provider or addiction specialist is reasonable — but CBD alone is not a proven standalone intervention for alcohol use disorder.
Casual combination of CBD and moderate social drinking is not a major safety concern for healthy adults — though additive sedation means you should always account for potential greater-than-expected impairment when combining both, and should not drive. The longer-term concern is for heavy regular drinkers using high-dose CBD daily: the combined hepatic burden and CNS effects merit monitoring.
The most underappreciated CBD-alcohol connection is hangxiety — where CBD's cortisol and serotonin mechanisms directly address the morning-after anxiety that many people find the most unpleasant alcohol effect. And the most exciting frontier is CBD's potential role in harm reduction for people who drink heavily — a research area where the preclinical signal is strong and human trials are overdue.
For daily cortisol management and sleep quality that supports both wellness and mindful drinking habits,PureCraft's Nano CBD Oil andCBD+CBN Sleep Gummies. Zero THC, nano-optimized, third-party tested, USA-grown hemp.
Medical Disclaimer | This article is for informational and educational purposes only and does not constitute medical advice. Alcohol consumption carries its own health risks independent of CBD. CBD should not be used to enable or justify greater alcohol consumption. For concerns about alcohol use disorder, speak with a qualified healthcare provider or addiction specialist. The FDA has not evaluated these statements. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.
Medical Disclaimer | Sauna use is contraindicated in certain cardiovascular conditions, pregnancy, and with medications that impair heat tolerance...
Read More
Medical Disclaimer | Cold water immersion is contraindicated in people with cardiovascular conditions, Raynaud's disease, hypertension, or cold ur...
Read More
Medical Disclaimer | This article is for informational and educational purposes only. Intermittent fasting and CBD supplementation should be appro...
Read More